Evolent Health, Inc. (EVH) |
| 3.74 -0.36 (-8.78%) 09-15 16:00 |
| Open: | 4.12 |
| High: | 4.12 |
| Low: | 3.71 |
| Volume: | 2,685,785 |
| Market Cap: | 421(M) |
| PE Ratio: | 28.77 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 5.03 |
| Resistance 1: | 4.53 |
| Pivot price: | 4.34 |
| Support 1: | 3.71 |
| Support 2: | 3.09 |
| 52w High: | 9.63 |
| 52w Low: | 2.095 |
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
| EPS | -4.490 |
| Book Value | 3.400 |
| PEG Ratio | 1.93 |
| Gross Profit | 3.199 |
| Profit Margin (%) | -24.08 |
| Operating Margin (%) | -1.34 |
| Return on Assets (ttm) | -0.8 |
| Return on Equity (ttm) | -67.0 |
Tue, 08 Sep 2026
Morgan Stanley slips under 5% in Evolent Health (NYSE: EVH) - Stock Titan
Wed, 26 Aug 2026
Evolent Health (NYSE: EVH) officer lines up 2026 stock sale - Stock Titan
Tue, 11 Aug 2026
Evolent Health, Inc. (EVH) Stock Analysis: A Healthcare Tech Player with a 46% Potential Upside - DirectorsTalk Interviews
Thu, 06 Aug 2026
Evolent Health, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Tue, 28 Jul 2026
Evolent Health Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Thu, 23 Jul 2026
Why Evolent Health (EVH) Stock Is Nosediving - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |